2023. Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s295. DOI:https://doi.org/10.25251/skin.7.supp.295.